Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study
Clinical trial NCT06820762 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06820762
- Sponsor
- The Second Affiliated Hospital of Dalian Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-28
- Primary completion
- 2026-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.